Precision Medicine

AMCP is your partner in navigating the application of precision medicine in managed care pharmacy to improve patient outcomes, lower drug costs, end ensure better medication management.
AMCP Precision Medicine Initiative
Logo box for the AMCP Unscripted Podcast

Unscripted - Advancing Personalized Medicine: From Promise to Practice

Personalized medicine has moved from concept to proven science—but implementation lags behind. In this episode of Unscripted, Daryl Pritchard, Senior Vice President of Science Policy at the Personalized Medicine Coalition, discusses how precision medicine is transforming care and where critical gaps remain. He shares findings from recent studies showing how many patients are still lost along the testing-to-treatment pathway, even in well-established areas like non-small cell lung cancer, and explains what’s needed to bridge those gaps. The conversation highlights the role of payers, providers, and policymakers in aligning science, practice, and policy to deliver truly individualized care.
Non Small Cell Lung Cancer Thumbnail

JMCP Outsert - Precision Oncology in NSCLC (Biomarker)

The lack of implementation of predictive biomarkers in clinical practice results in a significant number of individuals with NSCLC not deriving benefits from targeted treatments. Payers have the potential to shape various aspects of the precision oncology pathway, such as addressing biomarker test ordering, utilizing test results to inform treatment decisions, implementing quality measurements, and understanding cost-effectiveness.
Precision Medicine
Finger scanning Logo

Precision Medicine Initiative

Learn how AMCP is helping professionals and stakeholders navigate the application of precision medicine in managed care pharmacy to improve patient outcomes, lower drug costs, end ensure better medication management.
Precision Medicine